LabGenius

LabGenius uses a machine learning-driven evolution engine (EVA) to develop next-generation protein therapeutics. It leverages robotic automation, synthetic biology, and advanced machine learning to explore protein fitness landscapes and simultaneously optimize multiple drug properties. LabGenius is a private company backed by top-tier venture capital funds and is currently based in London.